"Designing Growth Strategies is in our DNA"

Vascular Plugs Market Size, Share & COVID-19 Impact Analysis, By Product Type (Arterial & Venous Embolization Plugs, Congenital Heart Malformation Closure Plugs, and Others), By Material (Titanium Nickel (Nitinol) and Others), By End-user (Hospitals & Clinics and Independent Catherization Labs), and Regional Forecasts, 2022-2029

Region : Global | Format: PDF | Report ID: FBI101122

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global vascular plugs market size was USD 109.9 million in 2021. The market is projected to grow from USD 116.2 million in 2022 to USD 178.5 million by 2029, exhibiting a CAGR of 6.3% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. Based on our analysis, the global market exhibited a decline of -11.0% in 2020 as compared to 2019. 


Vascular plugs are widely used to selectively occlude blood vessels across the vasculature. These plugs possess embolic materials and occlusion devices and are used as an alternative to embolic coils. These devices are also cost-effective, as multiple coils may be required to block a specific artery, whereas a single plug can perform the same function. As per the application, these devices can be categorized into arterial & venous embolization plugs, congenital heart malformation closure plugs, and others.


Globally rising prevalence of vascular disorders and an increasing number of peripheral embolization procedures is expected to boost the adoption rate of these devices during the forecast period. For instance, according to an article published by Hindawi in 2019, it was estimated that the prevalence of peripheral artery disease (PAD) was around 10.0% to 20.0% among the global population. The growing investment by market players in the research & development of technological advances is further expected to propel the market growth during the 2022-2029 period.


COVID-19 IMPACT


Decline in Non-essential Surgeries during COVID-19 to Hamper Sales of Vascular Plugs


The COVID-19 pandemic negatively impacted the global vascular plugs market growth in 2020. Key players in the market witnessed a decline in their revenues due to decrease in the volume of vascular procedures and lower sales of devices. For instance, Abbott’s structural heart business segment, which included vascular plugs, witnessed a decline of -10.9% in 2020 compared to 2019 due to decrease in sales of core products.


Also, in different healthcare settings, critical healthcare resources were shifted to manage COVID-19 patients, resulting in limiting non-essential hospital visits and decline in the number of non-essential embolization procedures. For instance, according to the data published by AK Journals, it was reported that the number of embolization procedures decreased to -37.5% in Eastern Europe interventional radiology department in 2020 as compared to the previous year. Lockdown restrictions also impacted the healthcare supply chain, causing disruption of supply lines during the pandemic. However, to minimize the impact, several guidelines were published to prioritize the necessary embolization techniques for patients with vascular diseases. For instance, the American College of Surgeons published COVID-19 guidelines for triage of vascular surgery patients in 2020, giving detailed information regarding surgeries that must be postponed and surgeries that were essential based on the patient's condition.


LATEST TRENDS


Request a Free sample to learn more about this report.


Rising Shift toward Shape Memory Polymers is a Prominent Trend


Shape Memory Polymers (SMPs) have been an exciting area for polymer innovation. The materials are made to remember the shape they were in and would return to the shape when triggered with some stimulus such as heat and light. The material serves a wide range of applications, which covers medical, industrial, electronics, textile, and others. During vascular embolization procedures, the SMP offers several unique advantages, such as it is highly compatible and exerts minimal force on anatomic boundaries.


This material is gaining popularity among significant players in the vascular plugs market. For instance, Shape Memory Medical Inc. developed an SMPs product family, including the IMPEDE, IMPEDE-FX Embolization Plugs, and IMPEDE-FX RapidFill. Also, these products are approved by the PMDA and CE Mark from the European Union. Hence, clinically proven advantages of using SMPs over alloys, such as nitinol & tin during intervention, have resulted in a gradual shift of manufacturers toward this new segment.


DRIVING FACTORS


Rising Prevalence of Vascular Diseases Globally to Boost Market Growth


Vascular conditions such as coronary artery disease, cerebrovascular disease, and peripheral artery diseases are leading causes of illness and death in both developed and emerging countries. The rising prevalence of these conditions is presenting a large pool of patients requiring treatment and undergoing vascular embolization procedures every year.



  • For instance, according to an article published in The Lancet, in August 2019, the global prevalence of peripheral artery disease (PAD) in people aged 25 years and above was estimated to be around 5.5%.


Additionally, these devices are clinically proven to be a viable alternative to embolic coils during an embolization procedure. These devices can be repositioned, and their release can also be controlled as compared to the coils, which have a risk of distally migrating and then causing non-targeted embolization. Thus, the globally increasing number of patients undergoing vascular embolization procedures combined with multiple uses of these plugs and the related advantages to the device over coils positively impacts demand and subsequently led to the market growth during the forecast period.


RESTRAINING FACTORS


High Cost Associated with Embolization Procedures & Lack of Reimbursement to Hamper Growth


Cost-effectiveness of vascular plugs with regards to embolic coils provides an added advantage to these devices for peripheral vascularization procedures. However, the cost of the device, along with the procedural costs, is one of the restricting factors for the uptake of these devices, especially in emerging countries. For instance, according to a report published by Boston Scientific Corporation, the hospital outpatient procedure for venous and arterial embolization costs around USD 10,043 in the U.S. Also, it was observed that the first hospital admission for embolization procedure does not serve as a permanent resolution of the expensive and debilitating procedure. Thus, the high cost of vascular embolization procedure along with the lack of favorable reimbursement policies in developing countries is anticipated to limit the adoption of these plugs during the forecast period.


SEGMENTATION


By Product Type Analysis


To know how our report can help streamline your business, Speak to Analyst


Strong Focus of Manufacturers on Arterial & Venous Embolization led to its Dominance in 2021


The arterial & venous embolization segment held a dominant share of the market in 2021 owing to the constant focus of market players to launch devices for arterial & venous embolization. For instance, in July 2021, Terumo Corporation introduced a new vascular plug, AZUR, in the market, which can be used to reduce or block the blood flow in arteries of the peripheral vasculature.


However, congenital heart malformation closure and other segments accounted for a comparatively lower market share in 2021. This was due to limited product availability with market players for these applications.


By Material Analysis


Distinct Advantages offered by Other Materials to Result in its Higher Growth During 2022-2029 Period


On the basis of material, the market is categorized into titanium nickel (nitinol) and others. In terms of revenue, the titanium nickel nitinol segment dominated the market owing to the wide usage of nitinol in the production of vascular plugs. Additionally, major players opting for nitinol for device production also contributed to the higher demand for the material in 2021. The other segment, which comprises materials like titanium nitride Tin and shapes memory polymers, is anticipated to register higher CAGR during the forecast period.


Clinical benefits offered by shape memory polymers, and Tin, have been pivotal in gradually shifting the established market players towards focusing on R&D and introducing new products in this segment. For instance, in March 2021, Shape Memory Medical Inc. received CE mark approval for their IMPEDE-FX RapidFill device, an expansion of IMPEDE family, biodegradable peripheral vascular embolization plugs made up of shape memory polymer.


By End-user Analysis


Higher Number of Embolization Procedures Performed in Hospitals & Clinics Lead to its Dominance During Forecast Period


Among end-users, the market is segmented into hospitals & clinics and independent catheterization labs. The hospitals & clinics segment is anticipated to dominate the global market during the forecast period. The dominance is due to a higher number of cardiac and peripheral vascularization procedures performed in hospitals & clinics. Also, adequate reimbursement provided by these settings, along with the rapid development of healthcare and hospital infrastructure, especially in developing countries, is fueling the demand for these devices from these settings globally.


On the other hand, the independent catheterization labs segment is anticipated to grow at a rapid pace during the forecast period. The growth is due to the increasing number of new independent labs across the globe. These individual facilities provide focused health care to their patients and thus, subsequently increasing the segment’s growth during the 2022-2029 period.


REGIONAL INSIGHTS


North America Vascular Plugs Market Size, 2022 (USD million)

To get more information on the regional analysis of this market, Request a Free sample


The vascular plugs market size in North America stood at USD 51.1 million in 2021. The dominance is attributed to several factors, such as the growing prevalence of peripheral artery disease in the U.S. & Canada, which is presenting a large patient pool undergoing surgical treatment. For instance, according to an article published in American Heart Journal in June 2021, the prevalence of PAD was estimated to be equivalent to 7.0%, thus affecting around 8.5 million people.


Europe accounted for the second-largest market share and is expected to grow at a significant CAGR. The increasing prevalence of cardiovascular diseases in the region is one of the major factors contributing to the growth of the market. For instance, according to European Heart Network, the cardiovascular disease contributes towards 4.5.0% of all deaths in Europe. Also, as per an article published in Epub in March 2021, Italy reported a higher prevalence of cardiovascular diseases, i.e., 12.9%. Thus, posing as a major healthcare burden in the country.


The market in Asia Pacific is poised to register a comparatively higher CAGR during the forecast period. A larger population suffering from peripheral vascular conditions, increasing diagnosis and treatment rates in countries such as China, India, and other southeast Asia countries, and improving healthcare infrastructure, is poised to drive the demand for these devices in the region during the forecast period.


Similarly, in Latin America and the Middle East & Africa, an increasing number of healthcare facilities and developing health care infrastructure is anticipated to boost the market growth during the forecast period.


KEY INDUSTRY PLAYERS


Abbott and Medtronic to Held Dominant Position with Strong Focus on Inorganic Strategies


The competition landscape is highly consolidated, with major players such as Abbott and Medtronic accounting for a major market share in 2021. At present, companies are constantly focusing on adopting inorganic growth strategies and acquiring other market players in order to establish their brand presence globally. For instance, in January 2018, BD (Becton, Dickinson and Company) announced the acquisition of CR Bard, Inc. The acquisition helped the company in expanding its portfolio for treatment of peripheral and coronary artery disease.


Also, the current scenario is characterized by an increasing proportion of manufacturers, such as ArtVentive Medical Group Inc., focusing on the introduction of advanced devices with an aim to establish their foothold in the global vascular plug market.



  • For instance, in July 2020, ArtVentive Medical Group Inc. launched a clinical study to evaluate the efficacy and technical success of ArtVentive endoluminal occlusion system (EOS) device for splenic embolization.


Few other key players operating in the global market are Terumo Corporation, EndoShape, Inc., and Lifetech Scientific.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • June 2021 - Abbott India, a subsidiary of Abbott, announced the launch of Amplatzer Piccolo Occluder, which is among the world’s first vascular plug that can be implanted in premature babies.

  • March 2021 - Shape Memory Medical Inc. announced that it received approval from the Pharmaceutical and Medical Devices Agency (PMDA) to commercially launch its IMPEDE-FX Embolization Plugin Japan.


REPORT COVERAGE


An Infographic Representation of Vascular Plugs Market

To get information on various segments, share your queries with us



The vascular plugs market report provides a detailed analysis of the market and focuses on key aspects such as industry share, company profiles, materials, product type, and end-user. Besides this, it offers insights into the overview of the market trends and highlights key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the growth of the market in recent years.


Report Scope & Segmentation


















































  ATTRIBUTE



  DETAILS



Study Period



2018-2029



Base Year



2021



Forecast Period



2022-2029



Historical Period



2018-2020



Unit



Value (USD million)



Segmentation



Product Type, Material, End-user, and Region



By Product Type




  • Arterial & Venous Embolization Plugs

  • Congenital Heart Malformation Closure Plugs

  • Others



By Material




  • Titanium Nickel (Nitinol)

  • Others



By End-user


 




  • Hospitals & Clinics

  • Independent Catherization Labs



By Geography




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)



  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)



Frequently Asked Questions

Fortune Business Insights says that the global market stood at USD 109.9 million in 2021 and is projected to reach USD 178.5 million by 2029.

In 2021, the market size was USD 109.9 million.

The market will exhibit steady growth at a CAGR of 6.3% during the forecast period (2022-2029).

By material, the titanium-nickel (nitinol) segment is set to lead the market.

The rising prevalence of vascular diseases and clinical benefits of plugs over other alternatives are the key factors driving the market.

Abbott and Medtronic are the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Mar, 2022
  • 2021
  • 2018-2020
  • 123

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Buy Now

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Ipsos
Lek
abbvie
Roche
3M

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X